TCM
TNGX icon

TCG Crossover Management’s Tango Therapeutics TNGX Stock Holding History

TCG Crossover Management’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$220M Sell
10,531,071
-2,231,023
-17% -$31.1M 6.3% 3
2025
Q4 		$113M Buy
12,762,094
+4,225,898
+50% +$36.4M 3.74% 4
2025
Q3 		$71.7M Sell
8,536,196
-2,199,804
-20% -$14.9M 3.53% 6
2025
Q2 		$55M Hold
10,736,000
– – 6.28% 2
2025
Q1 		$14.7M Hold
10,736,000
– – 2.01% 23
2024
Q4 		$33.2M Buy
+10,736,000
New +$49.8M 3.24% 10
2022
Q4 		– Sell
-1,172,250
Closed -$4.24M – 24
2022
Q3 		$4.24M Hold
1,172,250
– – 1.27% 16
2022
Q2 		$5.31M Sell
1,172,250
-82,250
-7% -$498K 2.26% 14
2022
Q1 		$9.51M Buy
+1,254,500
New +$10.9M 3.82% 10

Other funds holding TNGX

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
TGI
TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

TCG Crossover Management's TNGX Position: Q1 2026 in Review

TCG Crossover Management reduced its Tango Therapeutics (TNGX) stake by 17% in Q1 2026, selling an estimated $31.1M and leaving 10,531,071 shares worth $220M. The position accounts for 6.3% of the portfolio, ranked #3.

TCG Crossover Management first reported a position in TNGX in Q1 2022 and has held it in 9 quarters since. 194 funds tracked by Wall St. Rank hold TNGX as of Q1 2026.

  • TCG Crossover Management held 10,531,071 shares of Tango Therapeutics worth $220M as of Q1 2026.
  • TCG Crossover Management sold 2,231,023 Tango Therapeutics shares in Q1 2026, an estimated $31.1M.
  • Tango Therapeutics made up 6.3% of TCG Crossover Management's portfolio in Q1 2026, its #3 holding.
  • TCG Crossover Management first reported a position in Tango Therapeutics in Q1 2022 and has held it in 9 quarters since.
  • 194 funds tracked by Wall St. Rank held Tango Therapeutics as of Q1 2026.

Based on TCG Crossover Management's 13F filing for Q1 2026, filed 15 May 2026.